Gerd R Burmester

Jul 1, 2024 | jrheum.org | Gerd R Burmester |John R.P. Tesser |Anna Shmagel |Yanxi Liu

Key Indexing Terms:arthritisclinical trialsRheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects joints, causes progressive bone and cartilage damage, and impairs quality of life if treated inadequately.1,2 The primary goal of RA therapy is to achieve sustained remission or low disease activity (LDA).

Jun 27, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Gerd R Burmester

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The initial clinical outcomes of upadacitinib for RA “improved or were maintained” through 5 years. Major adverse cardiovascular events and venous thromboembolisms were infrequent.

May 23, 2024 | ard.bmj.com | Gerd R Burmester |Jacques-Eric Gottenberg |Roberto Caporali |Kevin L. Winthrop

Antirheumatic AgentsArthritis, RheumatoidTherapeuticsData availability statementData are available upon reasonable request. Anonymised individual patient data will be shared upon request for research purposes, dependent upon the nature of the request, the merit of the proposed research and the availability of the data and their intended use. The full data sharing policy for Gilead Sciences, Inc., can be found at https://www.gilead.com/about/ethics-and-code-of-conduct/policies.

Jul 3, 2023 | ard.bmj.com | Gerd R Burmester

Jul 2, 2023 | ard.bmj.com | Gerd R Burmester